GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eiken Chemical Co Ltd (TSE:4549) » Definitions » YoY EBITDA Growth

Eiken Chemical Co (TSE:4549) YoY EBITDA Growth : -9.45% (As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is Eiken Chemical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Eiken Chemical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -9.45%.

Eiken Chemical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円33.78.


Eiken Chemical Co YoY EBITDA Growth Historical Data

The historical data trend for Eiken Chemical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eiken Chemical Co YoY EBITDA Growth Chart

Eiken Chemical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 34.92 22.77 -7.84 -39.56

Eiken Chemical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -75.15 -64.15 -60.56 -9.45 -82.13

Eiken Chemical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Eiken Chemical Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(157.804-261.071)/ | 261.071 |
=-39.56 %

Eiken Chemical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(33.775-37.301)/ | 37.301 |
=-9.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eiken Chemical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Eiken Chemical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Eiken Chemical Co (TSE:4549) Business Description

Traded in Other Exchanges
N/A
Address
4-19-9 Taito, Taito-ku, Tokyo, JPN, 110-8408
Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.

Eiken Chemical Co (TSE:4549) Headlines

No Headlines